Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion type Assertion NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_head.
- NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion description "[RUNX1 mutations clustered in the intermediate-risk cytogenetic group (46 of 640, 7.2%; cytogenetically normal, 34 of 538, 6.3%), whereas they were less frequent in adverse-risk cytogenetics (five of 109, 4.6%) and absent in core-binding-factor AML (0 of 77) and acute promyelocytic leukemia (0 of 61).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_provenance.
- NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion evidence source_evidence_literature NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_provenance.
- NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion SIO_000772 21343560 NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_provenance.
- NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion wasDerivedFrom befree-20140225 NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_provenance.
- NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_assertion wasGeneratedBy ECO_0000203 NP551790.RAB27Ml-ZF8tjnfWzveXz7BkyO9yJrWQKxdNua64iQ1Ac130_provenance.